Efficacy and safety of biotechnological drugs for the treatment of moderate-to-severe psoriasis in the elderly population: a single-center, Italian experience.
Filippo VivianiGiorgio SpazzoliGiacomo ClarizioBianca Maria PiracciniFederico BardazziPublished in: Clinical and experimental dermatology (2024)
These results could provide a starting point for new and larger studies and guidelines for biologic treatment.